Literature DB >> 26755417

Use of a pre-analysis osmolality normalisation method to correct for variable urine concentrations and for improved metabolomic analyses.

Andrew J Chetwynd1, Alaa Abdul-Sada2, Stephen G Holt3, Elizabeth M Hill2.   

Abstract

Metabolomics analyses of urine have the potential to provide new information on the detection and progression of many disease processes. However, urine samples can vary significantly in total solute concentration and this presents a challenge to achieve high quality metabolomic datasets and the detection of biomarkers of disease or environmental exposures. This study investigated the efficacy of pre- and post-analysis normalisation methods to analyse metabolomic datasets obtained from neat and diluted urine samples from five individuals. Urine samples were extracted by solid phase extraction (SPE) prior to metabolomic analyses using a sensitive nanoflow/nanospray LC-MS technique and the data analysed by principal component analyses (PCA). Post-analysis normalisation of the datasets to either creatinine or osmolality concentration, or to mass spectrum total signal (MSTS), revealed that sample discrimination was driven by the dilution factor of urine rather than the individual providing the sample. Normalisation of urine samples to equal osmolality concentration prior to LC-MS analysis resulted in clustering of the PCA scores plot according to sample source and significant improvements in the number of peaks common to samples of all three dilutions from each individual. In addition, the ability to identify discriminating markers, using orthogonal partial least squared-discriminant analysis (OPLS-DA), was greatly improved when pre-analysis normalisation to osmolality was compared with post-analysis normalisation to osmolality and non-normalised datasets. Further improvements for peak area repeatability were observed in some samples when the pre-analysis normalisation to osmolality was combined with a post-analysis mass spectrum total useful signal (MSTUS) or MSTS normalisation. Future adoption of such normalisation methods may reduce the variability in metabolomics analyses due to differing urine concentrations and improve the discovery of discriminating metabolites associated with sample source.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  LCMS; Mass spectrometry; Metabolomics; NanoESI; Normalisation; Urine

Mesh:

Substances:

Year:  2015        PMID: 26755417     DOI: 10.1016/j.chroma.2015.12.056

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  12 in total

1.  Osmolality-based normalization enhances statistical discrimination of untargeted metabolomic urine analysis: results from a comparative study.

Authors:  Loïc Mervant; Marie Tremblay-Franco; Emilien L Jamin; Emmanuelle Kesse-Guyot; Pilar Galan; Jean-François Martin; Françoise Guéraud; Laurent Debrauwer
Journal:  Metabolomics       Date:  2021-01-02       Impact factor: 4.290

2.  Comparative analysis of creatinine and osmolality as urine normalization strategies in targeted metabolomics for the differential diagnosis of asthma and COPD.

Authors:  Mona M Khamis; Teagan Holt; Hanan Awad; Anas El-Aneed; Darryl J Adamko
Journal:  Metabolomics       Date:  2018-08-29       Impact factor: 4.290

3.  Evaluation of statistical techniques to normalize mass spectrometry-based urinary metabolomics data.

Authors:  Tyler Cook; Yinfa Ma; Sanjeewa Gamagedara
Journal:  J Pharm Biomed Anal       Date:  2019-09-03       Impact factor: 3.935

4.  Metabolite quantification: A fluorescence-based method for urine sample normalization prior to 1H-NMR analysis.

Authors:  James Gerard Wolfsberger; Emily C Hunt; Sai Sumedha Bobba; Sharifa Love-Rutledge; Bernhard Vogler
Journal:  Metabolomics       Date:  2022-10-19       Impact factor: 4.747

5.  Metabolite patterns predicting sex and age in participants of the Karlsruhe Metabolomics and Nutrition (KarMeN) study.

Authors:  Manuela J Rist; Alexander Roth; Lara Frommherz; Christoph H Weinert; Ralf Krüger; Benedikt Merz; Diana Bunzel; Carina Mack; Björn Egert; Achim Bub; Benjamin Görling; Pavleta Tzvetkova; Burkhard Luy; Ingrid Hoffmann; Sabine E Kulling; Bernhard Watzl
Journal:  PLoS One       Date:  2017-08-16       Impact factor: 3.240

6.  Identification of urinary metabolites that correlate with clinical improvements in children with autism treated with sulforaphane from broccoli.

Authors:  Stephen Bent; Brittany Lawton; Tracy Warren; Felicia Widjaja; Katherine Dang; Jed W Fahey; Brian Cornblatt; Jason M Kinchen; Kevin Delucchi; Robert L Hendren
Journal:  Mol Autism       Date:  2018-05-30       Impact factor: 7.509

7.  An NMR-Based Approach to Identify Urinary Metabolites Associated with Acute Physical Exercise and Cardiorespiratory Fitness in Healthy Humans-Results of the KarMeN Study.

Authors:  Sina Kistner; Manuela J Rist; Maik Döring; Claudia Dörr; Rainer Neumann; Sascha Härtel; Achim Bub
Journal:  Metabolites       Date:  2020-05-21

8.  High-Precision Automated Workflow for Urinary Untargeted Metabolomic Epidemiology.

Authors:  Isabel Meister; Pei Zhang; Anirban Sinha; C Magnus Sköld; Åsa M Wheelock; Takashi Izumi; Romanas Chaleckis; Craig E Wheelock
Journal:  Anal Chem       Date:  2021-03-19       Impact factor: 6.986

9.  Development of Biomarkers for Inhibition of SLC6A19 (B⁰AT1)-A Potential Target to Treat Metabolic Disorders.

Authors:  Kiran Javed; Qi Cheng; Adam J Carroll; Thy T Truong; Stefan Bröer
Journal:  Int J Mol Sci       Date:  2018-11-14       Impact factor: 5.923

10.  Normalizing Untargeted Periconceptional Urinary Metabolomics Data: A Comparison of Approaches.

Authors:  Ana K Rosen Vollmar; Nicholas J W Rattray; Yuping Cai; Álvaro J Santos-Neto; Nicole C Deziel; Anne Marie Z Jukic; Caroline H Johnson
Journal:  Metabolites       Date:  2019-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.